Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Biology

A subscription to JoVE is required to view this content.
You will only be able to see the first 20 seconds.

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
 

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Article doi: 10.3791/58133
June 28th, 2019

Summary June 28th, 2019

Cellular senescence is the key factor in the development of chronic age-related pathologies. Identification of therapeutics that target senescent cells show promise for extending healthy aging. Here, we present a novel assay to screen for the identification of senotherapeutics based on measurement of senescence associated β-Galactosidase activity in single cells.

Transcript

Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
simple hit counter